Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lilly Completes Acquisition of CoLucid Pharmaceuticals
Thursday, March 02, 2017Eli Lilly and Company announced the successful completion of its acquisition of CoLucid Pharmaceuticals Inc The tender offer for all outstanding shares of common stock of CoLucid at a price of per share expired as scheduled on Tuesday February...
Ligand Pharmaceuticals Expands License with Sermonix to Include Worldwide Rights for Oral Lasofoxifene
Wednesday, March 01, 2017Ligand Pharmaceuticals Incorporated announces that it has expanded its license with Sermonix Pharmaceuticals to include worldwide rights to develop and commercialize oral lasofoxifene Ligand originally licensed the US rights to oral lasofoxifene to S...
FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug XERMELO™ (telotristat ethyl)
Wednesday, March 01, 2017Lexicon Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has approved XERMELO telotristat ethyl mg as a first and only orally administered therapy for the treatment of carcinoid syndrome diarrhea in combination with somatos...
Baxter and ScinoPharm Announce Exclusive Strategic Partnership for Generic Oncology Injectables
Wednesday, March 01, 2017Baxter International Inc and ScinoPharm Taiwan Ltd announced a strategic partnership to develop manufacture and commercialize five injectable drugs used in a range of cancer treatments including lung cancer multiple myeloma and breast cancer as well...
RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137
Tuesday, February 28, 2017RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration today announced that its licensee for RGN GtreeBNT Co Ltd received a positive response from the US FDA for its Phase clinic...
Arsanis Inc., and Adimab Enter Into License Agreement
Tuesday, February 28, 2017Arsanis Inc a clinicalstage biopharmaceutical company developing targeted monoclonal antibodies for preemptive and postinfection treatment of serious infectious diseases and Adimab LLC the global leader in the discovery and optimization of fully huma...
Perrigo Signs Agreement To Divest Tysabri® Royalty Stream For Up To $2.85 Billion
Tuesday, February 28, 2017Perrigo Company plc a leading global provider of Quality Affordable Healthcare Products today announced it has signed a definitive agreement to divest its rights to the royalty stream from the global net sales of the multiple sclerosis drug Tysabri n...
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR
Monday, February 27, 2017Intellipharmaceutics International Inc NasdaqIPCI TSXI Intellipharmaceutics or the Company a pharmaceutical company specializing in the research development and manufacture of novel and generic controlledrelease and targetedrelease oral solid dosage...
Xynomic Pharma has Acquired Worldwide Rights of Abexinostat
Monday, February 27, 2017Xynomic Pharmaceuticals Inc an oncology drug research and development company today announced that it has acquired exclusive worldwide rights to develop manufacture and commercialize Abexinostat a potentially bestinclass innovative HDAC inhibitor tar...
Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
Monday, February 27, 2017Sanofi and Lonza announced today that they have entered into a strategic partnership to build and operate a largescale mammalian cell culture facility for monoclonal antibody production in Visp Switzerland The strategic partnership in the form of a j...
